Header Logo

Connection

CHARLES WYKOFF to Semaphorin-3A

Back to Details
This is a "connection" page, showing publications CHARLES WYKOFF has written about Semaphorin-3A.
CHARLES WYKOFF
Connection Strength
0.242
Semaphorin-3A
  1. New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway. Eye (Lond). 2025 Dec; 39(18):3209-3217.
    View in: PubMed
    Score: 0.242
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.